These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27856730)

  • 1. Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.
    Logan LK; Gandra S; Mandal S; Klein EY; Levinson J; Weinstein RA; Laxminarayan R;
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):352-359. PubMed ID: 27856730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
    Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
    Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa.
    Appaneal HJ; Caffrey AR; Lopes V; Piehl EC; Puzniak LA; LaPlante KL
    Microbiol Spectr; 2022 Oct; 10(5):e0233622. PubMed ID: 36005836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hospitalized patients with resistant or multidrug-resistant
    Raman G; Avendano EE; Chan J; Merchant S; Puzniak L
    Antimicrob Resist Infect Control; 2018; 7():79. PubMed ID: 29997889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015-2019.
    Lee YL; Ko WC; Hsueh PR
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0200021. PubMed ID: 34807753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012.
    Logan LK; Gandra S; Trett A; Weinstein RA; Laxminarayan R
    J Pediatric Infect Dis Soc; 2019 May; 8(2):136-142. PubMed ID: 29579216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality.
    Rodríguez NEG; Aguilera-Alonso D; Escosa L; Gómez-Gil MR; Manzanares Á; Ascaso MG; Bermejo-Gómez A; Abad MJG; Ramos AM; Núñez AS; Orellana MÁ; Cercenado E; Lozano JS; Calvo C; Baquero-Artigao F;
    J Hosp Infect; 2024 Jul; 149():56-64. PubMed ID: 38735628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the Veterans Affairs Healthcare System from 2009 to 2013.
    Appaneal HJ; Caffrey AR; Jiang L; Dosa D; Mermel LA; LaPlante KL
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):311-315. PubMed ID: 29310949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving trends among
    Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combination Antibiogram Evaluation for
    Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.
    Al-Orphaly M; Hadi HA; Eltayeb FK; Al-Hail H; Samuel BG; Sultan AA; Skariah S
    mSphere; 2021 May; 6(3):. PubMed ID: 34011686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020.
    Karlowsky JA; Lob SH; Siddiqui F; Akrich B; DeRyke CA; Young K; Motyl MR; Hawser SP; Sahm DF
    Int J Antimicrob Agents; 2023 May; 61(5):106772. PubMed ID: 36878411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand.
    Khuntayaporn P; Montakantikul P; Mootsikapun P; Thamlikitkul V; Chomnawang MT
    Ann Clin Microbiol Antimicrob; 2012 Sep; 11():25. PubMed ID: 22970983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
    Mustafa MH; Chalhoub H; Denis O; Deplano A; Vergison A; Rodriguez-Villalobos H; Tunney MM; Elborn JS; Kahl BC; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6735-6741. PubMed ID: 27572406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
    PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
    Motbainor H; Bereded F; Mulu W
    BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.